Image

Clinical Evaluation of the AccuCinch® Ventricular Restoration System in Patients Who Present with Symptomatic Heart Failure with Reduced Ejection Fraction (HFrEF): the CORCINCH-HF Study

Study on AccuCinch® for heart failure with reduced heart function.

Recruiting
18 years and older
All
Phase N/A
  • Simplified description (AI rewritten)
  • Technical description (Original)

The CORCINCH-HF Study is researching a device called the AccuCinch Ventricular Restoration System for patients with heart failure and reduced ejection fraction (HFrEF). Heart failure is when the heart doesn't pump blood well. Ejection fraction is a measure of how much blood the left ventricle pumps out with each heart beat. Participants will be randomly placed in one of two groups: one will get the device and standard heart failure treatment, and the other will get standard treatment only. Ejection fraction between 20% and 40% is required, and participants must be 18 or older.

  • Study Duration: Participants must be prepared for a long-term commitment as multiple follow-ups will be needed.
  • Eligibility: Participants should have had heart failure treatment for at least 90 days before joining and be stable on their current medication.
  • Risks: There may be risks associated with the device and procedures, so willingness to undergo tests and follow-ups is necessary.

Participants must be able to complete a six-minute walk test and agree to follow up. Certain heart conditions and recent surgeries may disqualify you. Always consult with your doctor to determine if joining the study is right for you.

Print
Study details
    Heart Failure with Reduced Ejection Fraction (HFrEF)
    Dilated Cardiomyopathy

NCT04331769

Ancora Heart, Inc.

13 December 2024

Contact a study center
Step 1 Get in touch with the nearest study center
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer  to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact

site

  Other languages supported:

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.